Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Avastin with Taxol and Carboplatin in Newly Diagnosed Ovarian Cancer
NCT00127920Phase 2Completed
- Sponsor
- Gynecologic Oncology Associates
- Start
- Aug 2004
- Primary completion
- Aug 2006
- Modality
- Monoclonal Antibodies
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of bevacizumab in ovarian cancer, fallopian tube cancer (PFTC) and primary peritoneal cancer (PPC), sponsored by Gynecologic Oncology Associates. Primary endpoints: Time to Tumor Progression and Response Rate. Started Aug 2004; status: completed.
02
Drugs
bevacizumab
03
Conditions
ovarian cancerfallopian tube cancer (PFTC)primary peritoneal cancer (PPC)
Beyond the preview
Go deeper on NCT00127920.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00127920.